FRNM
Freenome, Inc. Common stock
stockNASDAQ
At CloseOct 2, 2026 3:59:58 PM EDT
16.29USD+4.289%(+0.67)813,564
Pre-marketOct 2, 2026 8:17:30 AM EDT
15.66USD+0.229%(+0.04)
Loading…
Loading…
1.74B
Previous Close
$15.64
Beta
1.27
52-Week High
$17.50 2026-09-21
52-Week Low
$9.97 2026-07-29
SMA 50
$13.88
SMA 200
$13.82
Avg. Vol 10D
534,360
Avg. Vol 30D
864,884
Avg. Vol 90D
880,295
Relative Vol
0.94
107.45M
7.12M
6.63%
1,696,752
23.83%
2.14
55%/45%
86.91%
85.23%
2.4300%
350,000
24,879
52,318
116,470
Nov 11, 2026 (37d)
Sep 30, 2026
Abbott launches Freenome’s colorectal cancer screening test · 
MedTech Dive
Sep 24, 2026
GRAIL sets new 52-week high as FDA panel backs cancer test · 
Seeking Alpha
Sep 18, 2026
Freenome Inc stock hits all-time high at 17.21 USD · 
Investing.com
FRNM Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 16.19 | 2026-09-28 | +0.20% | 5.976 |
| 1M | 16.31 | 2026-09-04 | -0.54% | 1.820 |
| 3M | 13.01 | 2026-07-21 | +24.69% | 1.275 |
FRNM Stock Summary
Freenome, Inc. Common stock (NASDAQ:FRNM) stock price today is $16.22, and today's volume is 813,566. FRNM is up 3.726% today. The 30 day average volume is 864,884. FRNM market cap is $1.74B with 107.45M shares outstanding.